Effect of roxadustat on erythropoiesis and iron metabolism
Not Applicable
- Conditions
- renal anemia
- Registration Number
- JPRN-UMIN000045857
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have history of allergy for HIF-PH inhibitor. 2) Patients who are taking HIF-PH inhibitor. 3) Patients whose serum ferritin level 100 ng/mL and TSAT<20%. 4) Pregnant women. 5) Patients with bleeding, severe liver disease, malignant, chronic infection, autoimmune disease, polycystic kidney disease, active diabetic retinopathy. 6) Patients who are ineligible for participating the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method